Related Experiment Video
Updated: Jun 12, 2026

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
Published on: July 13, 2019
Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and update
Wana Manitpisitkul1, Nikita S Wilson, Abdolreza Haririan
1Department of Pharmacy, University of Maryland Medical Center, 22 South Greene Street, Baltimore, MD 21201, USA.
Importance Of The Field:
BK virus has emerged as an important cause of graft dysfunction and failure in renal transplant recipients. Risk factors for BK virus nephropathy (BKN) are not well established, but evidence suggests that it is the result of a complex interplay between multiple donor- and recipient-related factors.
Areas Covered In This Review:
The purpose of this article is to review the current understanding on the effect of various immunosuppressive agents on BK viral replication and the results of different reported immunosuppression reduction protocols.
What The Reader Will Gain:
The intensity of overall immunosuppression has been accepted as a major risk factor for the development of BKN. We review the data regarding the contribution of different anti-rejection agents to the risk of BK virus-induced graft injury.
Take Home Message:
Although reduction in immunosuppression on detection of BK viral replication appears to be the most successful means in preserving allograft function, data are emerging that support the stronger association of the disease with tacrolimus, in contrast to mycophenolate compounds. Therefore, initial dose reduction for tacrolimus may be more beneficial than this anti-metabolite preemptively or after diagnosis of BKN.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Chronic Kidney Disease I: Introduction
Acute Kidney Injury I: Introduction
Chronic Kidney Disease III: Interprofessional Care